John H. Dodd

2.1k citations

53 papers · 1.4k · h-index 23

Impact in

Organic Chemistry top 2%
- Synthesis and biological activity
- Catalytic C–H Functionalization Methods
- Multicomponent Synthesis of Heterocycles
- Synthesis and Biological Evaluation
- Synthesis and Characterization of Heterocyclic Compounds
Physiology top 5%

Papers in

Organic Chemistry 29
- Synthesis and biological activity 10
- Chemical synthesis and alkaloids 5
- Synthesis of Tetrazole Derivatives 4
Molecular Biology 28
- Melanoma and MAPK Pathways 16
- Phosphodiesterase function and regulation 4

Co-authors: James R. Henry (7 shared papers)Kenneth C. Rupert (6 shared papers)John J. Siekierka (5 shared papers)Steven M. Weinreb (4 shared papers)Druie Cavender (4 shared papers)Scott Wadsworth (4 shared papers)Joel C. Barrish (22 shared papers)Gilbert C. Olini (3 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (21 papers)Journal of Medicinal Chemistry (5 papers)Tetrahedron Letters (3 papers)Frontiers in Immunology (2 papers)The Journal of Organic Chemistry (2 papers)
Partner nations: United States Germany Japan

In The Last Decade

John H. Dodd

53 papers receiving 1.3k citations

Peers

Countries citing papers authored by John H. Dodd

Since Specialization

Citations

This map shows the geographic impact of John H. Dodd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Dodd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Dodd more than expected).

Fields of papers citing papers by John H. Dodd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Dodd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Dodd. The network helps show where John H. Dodd may publish in the future.

Co-authors

The 25 scholars most cited alongside John H. Dodd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John H. Dodd Line = papers co-authored together John H. Dodd links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Imidazopyrimidines, potent inhibitors of p38 MAP kinase Bioorganic & Medicinal Chemistry Letters ·Kenneth C. Rupert, James R. Henry, John H. Dodd, Scott Wadsworth, Druie Cavender, Gilbert C. Olini, Bohumila Fahmy, John J. Siekierka	2003	233
2	Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes. Molecular Pharmacology ·Robert F. Bruns, James H. Fergus, Linda L. Coughenour, G G Courtland, Thomas A. Pugsley, John H. Dodd, Francis J. Tinney	1990	94
3	Phosphodiesterase 7A-Deficient Mice Have Functional T Cells The Journal of Immunology ·Guchen Yang, Kim W. McIntyre, Robert M. Townsend, Henry Shen, William J. Pitts, John H. Dodd, Steven G. Nadler, Murray McKinnon, Andrew J. Watson	2003	79
4	Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, Joseph A. Furch, Chunjian Liu, Robert V. Moquin, James C. Lin, Steven H. Spergel, Kim W. McIntyre, David J. Shuster, Kathleen O'Day, Becky Penhallow, Chen-Yi Hung, Arthur M. Doweyko, Amrita V. Kamath, Hongjian Zhang, Punit Marathe, Steven B. Kanner, Tai-An Lin, John H. Dodd, Joel C. Barrish, John Wityak	2006	64
5	6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1H-pyrrolo[2,3-b]pyridine (RWJ 68354): A Potent and Selective p38 Kinase Inhibitor Journal of Medicinal Chemistry ·James R. Henry, Kenneth C. Rupert, John H. Dodd, Ignatius J. Turchi, Scott Wadsworth, Druie Cavender, Bohumila Fahmy, Gilbert C. Olini, Janet E. Davis, J. Lee Pellegrino-Gensey, Peter Schäfer, John J. Siekierka	1998	59
6	5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase Journal of Medicinal Chemistry ·Chunjian Liu, Stephen T. Wrobleski, James C. Lin, Gulzar Ahmed, Axel Metzger, John Wityak, Kathleen M. Gillooly, David J. Shuster, Kim W. McIntyre, Sidney Pitt, Ding Ren Shen, Rosemary F. Zhang, Hongjian Zhang, Arthur M. Doweyko, David Diller, Ian Henderson, Joel C. Barrish, John H. Dodd, Gary L. Schieven, Katerina Leftheris	2005	54
7	Azaxanthene Based Selective Glucocorticoid Receptor Modulators: Design, Synthesis, and Pharmacological Evaluation of (S)-4-(5-(1-((1,3,4-Thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and Its Methylene Homologue (BMS-791826) Journal of Medicinal Chemistry ·David S. Weinstein, Hua Gong, Arthur M. Doweyko, Mark Cunningham, Sium Habte, Jin Hong Wang, Deborah A. Holloway, Christine Burke, Ling Jie Gao, Victor R. Guarino, Julie Carman, John E. Somerville, David J. Shuster, Luisa Salter–Cid, John H. Dodd, Steven G. Nadler, Joel C. Barrish	2011	50
8	Synthesis of tetrahydroindeno[1,2-b]indol-10-ones and their rearrangement to [2]benzopyrano[4,3-b]indol-5-ones The Journal of Organic Chemistry ·James L. Bullington, John H. Dodd	1993	48
9	Benzothiazole based inhibitors of p38α MAP kinase Bioorganic & Medicinal Chemistry Letters ·Chunjian Liu, James C. Lin, Sidney Pitt, Rosemary F. Zhang, John S. Sack, Susan E. Kiefer, Kevin Kish, Arthur M. Doweyko, Hongjian Zhang, Punit H. Marathe, James M. Trzăskos, Murray McKinnon, John H. Dodd, Joel C. Barrish, Gary L. Schieven, Katerina Leftheris	2008	47
10	Identification of purine inhibitors of phosphodiesterase 7 (PDE7) Bioorganic & Medicinal Chemistry Letters ·William J. Pitts, Wayne Vaccaro, Tram Huynh, Katerina Leftheris, Jacques Y. Roberge, Joseph Barbosa, Junqing Guo, Baerbel R. Brown, Andrew J. Watson, Karen Donaldson, Gary C. Starling, Peter A. Kiener, Michael A. Poss, John H. Dodd, Joel C. Barrish	2004	38
11	Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, Robert V. Moquin, Sidney Pitt, Rosemary Zhang, Ding Ren Shen, Kim W. McIntyre, Kathleen M. Gillooly, Arthur M. Doweyko, John S. Sack, Hongjian Zhang, Susan E. Kiefer, Kevin Kish, Murray McKinnon, Joel C. Barrish, John H. Dodd, Gary L. Schieven, Katerina Leftheris	2008	37
12	Potent inhibitors of the MAP kinase p38 Bioorganic & Medicinal Chemistry Letters ·James R. Henry, Kenneth C. Rupert, John H. Dodd, Ignatius J. Turchi, Scott Wadsworth, Druie Cavender, Peter Schäfer, John J. Siekierka	1998	34
13	Synthesis of the carbon framework of olivin Tetrahedron Letters ·John H. Dodd, Steven M. Weinreb	1979	34
14	Dimethyl-diphenyl-propanamide Derivatives As Nonsteroidal Dissociated Glucocorticoid Receptor Agonists Journal of Medicinal Chemistry ·Bingwei Yang, David S. Weinstein, Lidia M. Doweyko, Hua Gong, Wayne Vaccaro, Tram Huynh, Hai-yun Xiao, Arthur M. Doweyko, Lorraine I. McKay, Deborah A. Holloway, John E. Somerville, Sium Habte, Mark Cunningham, Michele McMahon, Robert Townsend, David J. Shuster, John H. Dodd, Steven G. Nadler, Joel C. Barrish	2010	32
15	Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, Chunjian Liu, Robert V. Moquin, James C. Lin, Joseph A. Furch, Steven H. Spergel, Kim W. McIntyre, David J. Shuster, Kathleen O'Day, Becky Penhallow, Chen-Yi Hung, Steven B. Kanner, Tai-An Lin, John H. Dodd, Joel C. Barrish, John Wityak	2006	31
16	Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases Frontiers in Pharmacology ·Carl Spana, Andrew W. Taylor, David G. Yee, Marie Makhlina, Wei Yang, John H. Dodd	2019	30
17	Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure–activity relationships Bioorganic & Medicinal Chemistry Letters ·James Kempson, William J. Pitts, Joseph Barbosa, Junqing Guo, Omonike Omotoso, Andrew J. Watson, Karen Stebbins, Gary C. Starling, John H. Dodd, Joel C. Barrish, Raymond A. Felix, K.‐H. Fischer	2005	30
18	Development of a strategy for convergent total synthesis of the aureolic acid antitumor antibiotics The Journal of Organic Chemistry ·John H. Dodd, Ravi S. Garigipati, Steven M. Weinreb	1982	29
19	Utilization of a nitrogen–sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Shuqun Lin, Stephen T. Wrobleski, John Hynes, Sidney Pitt, Rosemary Zhang, Yi Fan, Arthur M. Doweyko, Kevin Kish, John S. Sack, Mary F. Malley, Susan E. Kiefer, John A. Newitt, Murray McKinnon, James M. Trzăskos, Joel C. Barrish, John H. Dodd, Gary L. Schieven, Katerina Leftheris	2010	26
20	ortho-Toluate Carbanion Chemistry: Sulfenylation and Selenation Synthesis ·Frank M. Hauser, Richard P. Rhee, S. PRASANNA, Steven M. Weinreb, John H. Dodd	1980	26

About John H. Dodd

John H. Dodd is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Immunology and Computational Theory and Mathematics, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (16 papers), Synthesis and biological activity (10 papers), Cytokine Signaling Pathways and Interactions (8 papers), Computational Drug Discovery Methods (7 papers), Estrogen and related hormone effects (5 papers), Chemical synthesis and alkaloids (5 papers), Phosphodiesterase function and regulation (4 papers) and Synthesis of Tetrazole Derivatives (4 papers). The work is most often cited by research in Organic Chemistry (849 citations), Physiology (79 citations), Toxicology (44 citations), Pharmacology (176 citations) and Molecular Biology (585 citations). John H. Dodd has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include James R. Henry, Kenneth C. Rupert, John J. Siekierka, Steven M. Weinreb, Druie Cavender, Scott Wadsworth, Joel C. Barrish, Gilbert C. Olini, Murray McKinnon and Arthur M. Doweyko. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Tetrahedron Letters, Frontiers in Immunology and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

John H. Dodd

Impact in

Papers in i

In The Last Decade

John H. Dodd

Peers

Countries citing papers authored by John H. Dodd

Fields of papers citing papers by John H. Dodd

All Works

About John H. Dodd

Explore authors with similar magnitude of impact

Papers in